Rosetta Genomics Ltd. (ROSGQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Nov 4, 2025, 4:00 PM EST
Rosetta Genomics Revenue
Rosetta Genomics had revenue of $870.00K in the quarter ending June 30, 2017, with 115.35% growth. This brings the company's revenue in the last twelve months to $2.86M, up 106.43% year-over-year. In the year 2016, Rosetta Genomics had annual revenue of $2.04M, down -29.08%.
Revenue (ttm)
2.86M
Revenue Growth
+106.43%
P/S Ratio
0.00
Revenue / Employee
33.24K
Employees
86
Market Cap
593.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2016 | 2.04M | -836.00K | -29.08% |
| Dec 31, 2015 | 2.88M | 1.55M | 116.65% |
| Dec 31, 2014 | 1.33M | 922.00K | 227.65% |
| Dec 31, 2013 | 405.00K | 204.00K | 101.49% |
| Dec 31, 2012 | 201.00K | 98.00K | 95.15% |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| China New Energy Group Co. | 12.51M |
| Northwest Biotherapeutics | 1.09M |